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Cat scratch's disease caused by Bartonella henselae, is known to be a self-limited benign
process in immunocompetent children. The association with neurologic manifestations is
very uncommon especially in patient with no immunologic defects and in cases without
speciﬁc treatment. A 7 years old male patient, without any immunocompromised defect,
presented an atypic presentation of the cat scratch disease. The patient came to the
hospital in two opportunities in a status epilepticus, in both cases the diagnosis was
encephalitis by Bartonella henselae and the evolution with treatment was monitored with
PCR (polymerase chain reaction) in cerebrospinal ﬂuid and blood, as well as IFI (IgM,
IgG) serology (indirect immunoﬂuorescence). The patient had a favorable clinical and
laboratory evolution for 6 months showing no recurrence of the disease.1. Introduction
Bartonella henselae (B. henselae) is a gram negative bacillus
with more frequent cases in winter and autumn. CDC reports
2.5 conﬁrmed cases per 100000 in the USA [1]. The disease is
more prevalent in children and young people which are
the 80% of cases. The disease has a wide clinical spectrum,from an isolated lymphadenopathy to a systemic compromise,
affecting both immunocompetent or immunodeﬁcient patients
[2,3]. The 5%–25% of the immunocompetent patients have
an atypical presentation of this disease with extranodal
dissemination and systemic compromise which gives many
different manifestations. From this atypic cases, 1%–7% can
present with neurologic complication: convulsions (40%–
50%), status epilepticus (46%–80%) and other such as
meningitis, encephalitis, myelitis, radiculitis and peripheral
neuropathy [4] manifested more frequent in children between 7
and 12 years old.
The atypical presentation of this disease can be presented
with gastrointestinal manifestations: Micro hepatosplenic ab-
scesses and hepatitis, ocular manifestations like retinitis, cho-
roiditis, optic neuritis and oculoglandular syndrome Parinaud
(2%–17%) [5,6]. Skeletal manifestations (0.3%), osteitis,
osteomyelitis, paraspinal abscess and reactive arthritis.
Approximately 2% of patients develop serious and sometimes
fatal complications [7].ess article under the CC BY-NC-ND license (http://
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formation and laboratory. At least one of the following three:
Isolated regional lymphadenopathy, history of contact with cat at
least for 1 year with or without primary inoculation. However,
there is not always a clear history of contact or serological
laboratory testing for antibodies to B. henselae. The CDC from
Atlanta-EUA has established the diagnosis criteria with positives
values of IgG higher than 1:64, speciﬁc gender 93%–96%, but it
is not deﬁned to the species [8].
For that reason, the PCR takes relevance and the diagnostic is
conﬁrming with a sensibility of 76% and a speciﬁcity of 100% in
blood or cerebrospinal ﬂuid (CSF) samples [9].
In general, the disease is self-limited in immunocompetent
patients, starting with regional lymphadenopathy sometimes
follow by fever for 1–3 weeks after the scratch, bite or lick of the
cat and ends in 6–12 weeks with no treatment.
In the atypical presentations the pathophysiology of the en-
cephalopathy is unknown. Different theories such as direct in-
vasion, neurotoxin effect, vasculitis or immune response have
been postulated [7,10,11]. Clinical manifestations starts after 2
weeks of infection, like headache, mental disturbance,
convulsions, status epilepticus, etc.
2. Case report
A 7 years old male from Lima, Peru, was referred from a pri-
mary attention centre to the emergency room of Edgardo Reba-
gliati Matins Hospital. Four hours before admission, the patient
was presented with a sudden onset generalized tonic-clonic crisis
lasted 5 min approximately without regaining consciousness,
followed by a right hemiparesis and difﬁculty breathing requiring
prompt ICU transfer and intubation. Once on the ICU, the patient
was diagnosed with a convulsive status, to discard viral enceph-
alitis because of the history of auto limited high temperature one
week before the admission. CSF analysis and a cerebral CT scan
where reported as normal. After 24 h, the patient was extubated
and remaining confused and with visual hallucinations.
The ﬁrst hospital auxiliary tests were as follows. Cerebro-
spinal ﬂuid-CSF: Cells: 2/mL, Glucose: 91 mg/dl, Protein:
20 mg/dl; Multiple RT-Kit: Herpes simplex virus I–II, Varicella
zoster, Cytomegalovirus, Epstein Barr, Herpes virus VI, VII,
VIII, Enterovirus: all negative; Toxicological analysis: Negative;
Brain scan: Normal; MRI of the brain: Normal; Electroenceph-
alogram: Basal activity slow for the age; Thyroid Proﬁle: Normal;
Immunity (IgM, IgG, IgA, C3, C4): Normal; HIV: Negative;
Lymphocytes CD4–CD8: Normal; Thoracic X-ray: Normal.
Next day, fever was presented again, antibiotic coverage with
ceftriaxone and clindamycin for 5 d was initiated due to aTable 1
Treatment and monitoring laboratory.
Treatment
First hospitalization CRO+ CLI 4 d, AZM 5 d –
Second hospitalization CIP + SXT + RIF 14 d Posit
RIF + AZM Posit
Discharge Complete RIF + AZM 14 d –
Control 6th Month Nega
a Positive: antibodies; Negative: no antibodies; early infection: values of I
infection: values of IgG > 0 = 1:120.suspected aspirative pneumonia. This treatment is suspended by
good evolution of respiratory symptoms, less temperature and
normal chest radiograph. Hallucinations persisted and were
associated to orolingual involuntary movements. The patient got
better so he was transferred to the General Pediatric Area where
lineal injuries of a scratch on the skin of the superior and inferior
members were reported. The relatives referred to have 2 cats as
pets, so the empiric treatment with azithromycin 350 mg/d was
started as empiric treatment for cat scratch's disease, while
serology was pending. Patient was discharged due to neuro-
logical improvement.
Six days after discharged, the patient was readmitted due to
a new episode of convulsive status and fever not quantiﬁed of
4 d of evolution. The results of IFI were positive for
B. henselae and treatment with ciproﬂoxacin 300 mg/12 h Oral
cotrimoxazole 110 mg/6 h Ev and rifampicin 450 mg/24 h Oral
was initiated.
He was evaluated by the Pediatric Neurology and infectology
department, who suggested to maintain Rifampicin, initiate with
macrolide, a PCR ampliﬁcation studies in CSF for B. henselae,
retest for Bartonella serology, ophthalmology evaluation, MRI
of the brain, echocardiogram, Thoracoabdominal CT-Scan and
immunology studies. With treatment indicated evolves with
neurological improvement.
The second hospital auxiliary tests were as follows. Anti
receptor antibody N-methyl-D-aspartate: Negative; Echocardio-
gram: Minimal tricuspid insufﬁciency-Normal; Electroencepha-
logram: Quick diffuse activity; Ophthalmic fundus examination:
Discs with slight blurring at baseline in both eyes; Visual evoked
potential: Normal; Cerebrospinal ﬂuid: Cells: 2/mL, Glucose:
44 mg/dl, Protein: 18 mg/dl; Determination of visual acuity: 20/
20 both eyes, anisocoria a slight predominance of left eye;
Abdominal ultrasound: Mild hepatosplenomegaly.
In the second week of treatment, he was reevaluated by the
Pediatric Infectologist; for the appearance of diplopia and
persistent headache. He presents an optic fundus with efface-
ment of the optical disc in both eyes. A B-PCR study in CSF and
in blood was reported as positive for Bartonella genus (Table 1).
The normal MRI helps to exclude cerebrovascular event, met-
astatic disease and autoimmune encephalitis, due to the suspi-
cious of a bacterial infection, azithromycin and rifampicin is
restarted with neurological signs and symptoms in remission and
normal fundoscopy.
The patient was discharge with the same antibiotic treat-
ment and a control with PCR in blood and serology IFI IgG-
IgM for BH. The PCR negative and serology was still positive
BH IgG1: 64(+), IgM > 1:20(+), so the patient was advised
to complete the 4 weeks of antibiotic treatment. PhenobarbitalIFI PCR
IgG IgM Blood CSF
– – –
ive 1:256a Positive >1:20b – –
ive 1:64a Positive <1:20b Positive Positive
– Negative –
tive Negative – –
gG > 0 = 1:256. b Positive: antibodies; Negative: no antibodies; early
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5 months after pediatric infectiologist and neurologist
evaluation.
Currently the patient is asymptomatic with negative IFI
serology, negative IgG in the 6th moth of tracing.
3. Discussion
B. henselae is the etiological agent of the cat scratch's dis-
ease. The history of the scratch or bite of the cat is a useful
criteria for the diagnosis, however it is not always reported [7].
As in this case, the diagnosis was delayed due to the lack of
awareness regarding the presence of the skin lesion and the
epidemiological information.
Most of the patients with CSD present with fever and
lymphadenopathy near the skin lesion and with a history of
contact with cats. On the other hand, atypical clinical manifes-
tations are very rare with a variable presentation including:
prolonged fever of unknown origin and hepatosplenic, ocular
and neurological manifestations [12]. Neurological symptoms are
rare specially in immunocompetent patients [4].
The diagnosis of the B. henselae as the etiological agent of
CSD is not easy done due to the limited resources which are not
available in all the medical centers and as well as the difﬁcult
isolation of the bacteria [12,13]. For that reason, most of the times
the diagnosis is clinical without etiology conﬁrmation. Another
diagnosis difﬁculty is that in the children with encephalitis are
suspected to have a viral or bacterial etiology different from
bartonelosis [14].
Our patient without any previous pathological event is
admitted to the IUC twice with encephalitis and convulsive
status, where it was done multiple testing discarding viral and
autoimmune encephalitis besides negative immunodeﬁciency
studies. In front of the suspicious of CSD, with a wider history
of contact and the good neurologic evolution with treatment.
The patient is discharge after 9 d with an empiric treatment of
azithromycin and IFI serology of B. henselae as outpatient. In
addition, some studies indicated that the beneﬁt of one or other
antibiotic therapy is not conﬁrmed at all, especially in immu-
nocompetent children 1 as our case. In fact there is no an ideal
treatment that was stablished already [15]. Additionally, studies
may differ in the recommendations of antibiotic treatment for
bartonellosis, especially in immunocompetente hosts as our
patient [15].
Nevertheless, our patient in his ﬁfth day of treatment as an
outpatient with azithromycin, was readmitted in a convulsive
status with signs of encephalitis and the diagnosis was conﬁrmed
with positive serology IgM-IgG for B. henselae. And cipro-
ﬂoxacin 21mg/kg/24 h, trimethoprim-sulfametoxazol 16mg/kg/
24 h, rifampicin 14 mg/kg/24 h for 14 d where added in the ICU.
The therapy was decided after bacterial antibiotic resistance
studies to macrolides, ﬂuoroquinolones, tetracyclines, rifam-
picin, and trimethoprim-sulfamethoxazole, being the most
effective rifampicin 87%, ciproﬂoxacin 84%, intravenous
gentamicin 73% and TMP/SMX 58%. However, there is not a
consensus regarding the ideal therapeutic regimen [15,16].
It is proposed again a therapy considering the mechanisms of
the B. henselae against de CNS which are persistent bacterial
load in CSF, autoimmunity, critical effect of the toxin [7,11,17].
Facing the readmission and persistent symptomatology and
suspicious ocular impairment [5] we must have an etiology
diagnosis based on persistent of bacterial activity in the CSFin an immunocompetent child, for that reason we make PCR,
blood and CSF serology with combine treatments. The utility
of the molecular techniques (PCR) for the diagnosis of
encephalitis due to B.H. and other atypical etiologies gains
special attention in the need to establish a bacterial load in
CSF and blood specimen [9].
To date, the recommended treatment for BH is rifampicin
with azithromycin. Different authors use rifampicin in their
multiple antibiotics therapy [17,18]. Because of this penetration
into the CSF and recommended to be associated with a
macrolides in children, especially if recurrences [7,19].
However, there is a lack of evidence regarding the treatment
in immunocompetent patients with atypical presentation
involving neurological manifestations, in whom severe
sequelae and fatal cases have been reported [7].
Our patient after 6 months of treatment reported has no
recurrence, he is asymptomatic without anti convulsive therapy
and with negative IgM-IgG values for BH in his last control.
Regarding the positive serology in 1:16 or greater, which usually
indicates acute illness, it has been reported that can remain
positive in up to 3 months in the 50% of cases. The IgM anti-
bodies are not usually detected and a negative result does not
rule out the disease. Higher IgG levels, greater than 1:256 is
evidence of actual or previous infection of Bartonella. IgG
levels also fall and 75% are negative after a year. Evidence
shows that some patients never reach values of detectable anti-
bodies. For that reason, disadvantages of the serologic diagnosis
include variable sensitivity and speciﬁcity reported values and
the inability to distinguish between active or previous infection
[20].
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